Coya Therapeutics (COYA) SEC Filings & 10K Form

$8.60
-0.13 (-1.49%)
(As of 10:56 AM ET)

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
05/09/2024
3:20 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:21 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:40 PM
Coya Therapeutics (Filer)
Form ARS
03/28/2024
3:30 PM
Coya Therapeutics (Filer)
Form DEF 14A
03/28/2024
3:35 PM
Coya Therapeutics (Filer)
Form DEFA14A
03/19/2024
7:21 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:27 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:46 PM
Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
Form SC 13G/A
02/07/2024
5:55 PM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
02/02/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:15 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
01/04/2024
3:46 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/04/2024
3:05 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
7:00 AM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
8:46 AM
Coya Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/20/2023
7:35 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
6:30 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
8:03 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
8:07 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/21/2023
7:15 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
7:00 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2023
6:05 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:09 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2023
8:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2023
8:05 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
4:01 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
4:08 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
3:16 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
4:01 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
3:39 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:COYA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners